Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Formation of lactones from sialylated MUC1 glycopeptides.

Pudelko M, Lindgren A, Tengel T, Reis CA, Elofsson M, Kihlberg J.

Org Biomol Chem. 2006 Feb 21;4(4):713-20. Epub 2006 Jan 19.

PMID:
16467946
2.

Chemoenzymatic synthesis of sialylated glycopeptides derived from mucins and T-cell stimulating peptides.

George SK, Schwientek T, Holm B, Reis CA, Clausen H, Kihlberg J.

J Am Chem Soc. 2001 Nov 14;123(45):11117-25.

PMID:
11697954
3.

An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.

Ohyabu N, Hinou H, Matsushita T, Izumi R, Shimizu H, Kawamoto K, Numata Y, Togame H, Takemoto H, Kondo H, Nishimura S.

J Am Chem Soc. 2009 Dec 2;131(47):17102-9. doi: 10.1021/ja903361f.

PMID:
19899793
5.
6.
7.

Synthesis of oxime-linked mucin mimics containing the tumor-related T(N) and sialyl T(N) antigens.

Marcaurelle LA, Shin Y, Goon S, Bertozzi CR.

Org Lett. 2001 Nov 15;3(23):3691-4.

PMID:
11700114
8.

Stereoselective synthesis of sialylated tumor-associated glycosylamino acids.

Corcilius L, Payne RJ.

Org Lett. 2013 Nov 15;15(22):5794-7. doi: 10.1021/ol402845e. Epub 2013 Oct 25.

PMID:
24160308
9.
10.

Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.

Marcos NT, Pinho S, Grandela C, Cruz A, Samyn-Petit B, Harduin-Lepers A, Almeida R, Silva F, Morais V, Costa J, Kihlberg J, Clausen H, Reis CA.

Cancer Res. 2004 Oct 1;64(19):7050-7.

11.

One-pot multi-enzyme (OPME) chemoenzymatic synthesis of sialyl-Tn-MUC1 and sialyl-T-MUC1 glycopeptides containing natural or non-natural sialic acid.

Malekan H, Fung G, Thon V, Khedri Z, Yu H, Qu J, Li Y, Ding L, Lam KS, Chen X.

Bioorg Med Chem. 2013 Aug 15;21(16):4778-85. doi: 10.1016/j.bmc.2013.02.040. Epub 2013 Mar 7.

12.

Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.

Tarp MA, Sørensen AL, Mandel U, Paulsen H, Burchell J, Taylor-Papadimitriou J, Clausen H.

Glycobiology. 2007 Feb;17(2):197-209. Epub 2006 Oct 18.

PMID:
17050588
13.

Synthetic glycopeptides from the mucin family as potential tools in cancer immunotherapy.

Becker T, Dziadek S, Wittrock S, Kunz H.

Curr Cancer Drug Targets. 2006 Sep;6(6):491-517. Review.

PMID:
17017874
14.

Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.

Freire T, Bay S, von Mensdorff-Pouilly S, Osinaga E.

Cancer Res. 2005 Sep 1;65(17):7880-7.

15.

Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism.

Santos-Silva F, Fonseca A, Caffrey T, Carvalho F, Mesquita P, Reis C, Almeida R, David L, Hollingsworth MA.

Glycobiology. 2005 May;15(5):511-7. Epub 2004 Dec 15.

PMID:
15604091
16.

Production and characterization of a monoclonal antibody (BBH5) directed to ganglioside lactone.

Bouchon B, Levery SB, Clausen H, Hakomori S.

Glycoconj J. 1992 Feb;9(1):27-38.

PMID:
1392563
17.

High-performance CE: an effective method to study lactonization of alpha2,8-linked oligosialic acid.

Yu YP, Cheng MC, Wu SH.

Electrophoresis. 2006 Nov;27(22):4487-99.

PMID:
17054086
18.

Identifying lactone hydrolysis in pharmaceuticals. A tool for metabolite structural characterization.

Yi L, Bandu ML, Desaire H.

Anal Chem. 2005 Oct 15;77(20):6655-63.

PMID:
16223253
19.

Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core.

Kinarsky L, Suryanarayanan G, Prakash O, Paulsen H, Clausen H, Hanisch FG, Hollingsworth MA, Sherman S.

Glycobiology. 2003 Dec;13(12):929-39. Epub 2003 Aug 18.

PMID:
12925576
20.

Efficient synthesis of MUC4 sialylglycopeptide through the new sialylation using 5-acetamido-neuraminamide donors.

Okamoto R, Souma S, Kajihara Y.

J Org Chem. 2008 May 2;73(9):3460-6. doi: 10.1021/jo702609p. Epub 2008 Mar 25.

PMID:
18361519

Supplemental Content

Support Center